Table 1.
Date | Treatment |
---|---|
April to May 2005 | Two induction regimens: |
(1) Cytarabine + daunorubicin (7 + 3) | |
(2) Cytarabine + idarubicin (4 + 3) | |
September 2005 | Pre-transplant mobilization: |
Cyclophosphamide + total body irradiation | |
September 2005 | Allogeneic stem cell transplant |
August to September 2010 | Three high-dose regimens: |
(1) FLAG-Ida (fludarabine, cytarabine, G-CSF, and idarubicin) | |
(2) High-dose cytarabine | |
(3) Etoposide | |
November 2010 | Investigational treatment: |
Low-dose cytarabine + ribavirin | |
December 2010 | Three salvage chemotherapy regimens: |
(1) Mitoxantrone | |
(2) Hydroxyurea | |
(3) Etoposide + cyclophosphamide | |
January to February 2011 | Investigational treatment: |
Darinaparsin |